As shown in Figures 3A,B, higher levels of p-Akt/Akt and p-mTOR/mTOR were observed after treatment with 5, 10, and 15 μg/ml OSA-Exos than in the control (0 μg/ml) from the same OSA patient. Here, AKT1 is linked to obstructive sleep apnea syndrome.